Shares of OpGen, Inc. (NASDAQ:OPGN – Get Free Report) crossed above its 50-day moving average during trading on Thursday . The stock has a 50-day moving average of $2.35 and traded as high as $4.20. OpGen shares last traded at $4.17, with a volume of 14,173 shares traded.
Wall Street Analysts Forecast Growth
Separately, StockNews.com began coverage on shares of OpGen in a research note on Friday. They issued a “sell” rating on the stock.
Read Our Latest Report on OpGen
OpGen Price Performance
About OpGen
OpGen, Inc, a precision medicine company, engages in developing and commercializing molecular microbiology solutions in the United States and internationally. Its product portfolio includes Acuitas AMR Gene Panel, an in vitro diagnostic (IVD) test for the detection and identification of various bacterial nucleic acids and genetic determinants of antimicrobial resistance (AMR) from bacterial colonies isolated from any specimen, as well as Curetis CE-IVD-marked polymerase chain reaction-based SARS-CoV-2 test kits.
Featured Stories
- Five stocks we like better than OpGen
- 3 Grocery Stocks That Can Help Take a Bite Out of Inflation
- Tariff Exemptions Set the Stage for a Taiwan Semiconductor Rally
- What Makes a Stock a Good Dividend Stock?
- Mitigating Tariffs: 3 Stocks to Gain From a Weaker U.S. Dollar
- Dividend King Proctor & Gamble Is A Buy On Post-Earnings Weakness
- Broadcom’s Apple Relationship: AI Opportunity Meets Tariff Risk
Receive News & Ratings for OpGen Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for OpGen and related companies with MarketBeat.com's FREE daily email newsletter.
